BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/15/2014 8:54:00 PM | Browse: 463 | Download: 555
Publication Name World Journal of Gastroenterology
Manuscript ID 2435
Country South Korea
Received
2013-02-21 10:06
Peer-Review Started
2013-02-22 08:20
To Make the First Decision
2013-03-11 15:07
Return for Revision
2013-03-17 18:48
Revised
2013-04-12 17:42
Second Decision
2013-06-03 11:31
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2013-06-04 08:26
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2013-07-25 16:53
Publish the Manuscript Online
2013-08-06 09:19
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Transplantation
Manuscript Type Autobiography
Article Title Clinical outcome in patients with hepatocellular carcinoma after living-donor liver transplantation
Manuscript Source Invited Manuscript
All Author List Ho Joong Choi, Dong Goo Kim, Gun Hyung Na, Jae Hyun Han, Tae Ho Hong and Young Kyoung You
Funding Agency and Grant Number
Corresponding Author Dong Goo Kim, MD, PhD, Hepatobiliary-Pancreas Surgery and Liver Transplantation Division, Department of Surgery, Seoul St. Mary's Hospital, The Catholic University of Korea, 505 Banpo-dong, Seocho-gu, Seoul 137-701, South Korea. kimdg@catholic.ac.kr
Key Words Hepatocellular carcinoma; Living donor liver transplantation; Selection criteria; Milan criteria; University of California; San Francisco criteria; Barcelona Clinic Liver Cancer; Cancer of the Liver Italian Program
Core Tip Liver transplantation (LT) for hepatocellular carcinoma (HCC) is known to be the best therapeutic option. To obtain a good result, it is important to select appropriate LT candidates from among HCC patients. For living-donor liver transplantation (LDLT), investigation of the efficacy of such criteria will facilitate adoption of extended criteria in LDLT. We defined the selection criteria according to risk factors for recurrence based on our results and compared them with other criteria or scoring systems, such as the Milan and University of California, San Francisco criteria, tumor node metastasis and Barcelona Clinic Liver Cancer staging, and the Cancer of the Liver Italian Program scoring system.
Publish Date 2013-08-06 09:19
Citation Choi HJ, Kim DG, Na GH, Han JH, Hong TH, You YK. Clinical outcome in patients with hepatocellular carcinoma after living-donor liver transplantation. World J Gastroenterol 2013; 19(29): 4737-4744
URL http://www.wjgnet.com/1007-9327/full/v19/i29/4737.htm
DOI http://dx.doi.org/10.3748/wjg.v19.i29.4737
Full Article (PDF) WJG-19-4737.pdf
Manuscript File 2435-Review.doc
Answering Reviewers 2435-Answering reviewers.doc
Copyright License Agreement 2435-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate 2435-Language certificate.pdf
Peer-review Report 2435-Peer review(s).pdf
Scientific Editor Work List 2435-Scientific editor work list.doc